bromocriptine has been researched along with Tricuspid Incompetence in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Au, WL; Chan, YH; Lee, RK; Ng, KK; Tan, LC; Tan, NC | 1 |
Abad, A; Aller, J; Batista, E; Doltra, A; García-Pavía, P; Halperin, I; Lucas, T; Mirelis, JG; Mora, M; Puig-Domingo, M; Santos, AE; Sitges, M; Varela, C | 1 |
2 other study(ies) available for bromocriptine and Tricuspid Incompetence
Article | Year |
---|---|
Bromocriptine use and the risk of valvular heart disease.
Topics: Aged; Aortic Valve Insufficiency; Bromocriptine; Dopamine Agonists; Dose-Response Relationship, Drug; Echocardiography, Doppler; Female; Heart Valve Diseases; Humans; Male; Mitral Valve Insufficiency; Parkinson Disease; Receptor, Serotonin, 5-HT2B; Risk Factors; Severity of Illness Index; Tricuspid Valve Insufficiency | 2009 |
No clinically significant valvular regurgitation in long-term cabergoline treatment for prolactinoma.
Topics: Adolescent; Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Cross-Sectional Studies; Echocardiography; Ergolines; Female; Humans; Male; Middle Aged; Prolactinoma; Retrospective Studies; Tricuspid Valve Insufficiency; Young Adult | 2012 |